CYP19A1 and obesity disorder: Given the findings above, one would raise the question whether a vicious cycle is there for obesity and estrogens, as the one described for T. Indeed, in preclinical studies, adipose tissue inflammation and insulin resistance were found to reduce aromatase expression, which returned to normal levels with improvements in the factors above [36].